Casdin Capital
Status
ACTIVE
Global HQ
Colorado, United States
Countries of investment
- USA
Investment stages
- Seed
- Series A
- Series B
Industries
- AI
- Fintech
- Health Tech
- Blockchain
- Crypto
About
Casdin Capital is a pioneering life sciences investment firm based in New York. The firm invests in companies leveraging advanced molecular information to drive innovation in Healthcare, BioTech, Synthetic Biology, and Technology. It emphasizes patience, persistence, and strong relationships in its investment strategy. Notable sector focuses include precision medicine, genomics, synthetic biology, and advanced biopharmaceuticals. Among its portfolio are companies such as 23andMe, 4D Molecular Therapeutics, and A2 Biotherapeutics.
Casdin Capital is a pioneering life sciences investment firm based in New York. The firm invests in companies leveraging advanced molecular information to drive innovation in Healthcare, BioTech, Synthetic Biology, and Technology. It emphasizes patience, persistence, and strong relationships in its investment strategy. Notable sector focuses include precision medicine, genomics, synthetic biology, and advanced biopharmaceuticals. Among its portfolio are companies such as 23andMe, 4D Molecular Therapeutics, and A2 Biotherapeutics.
Investment Thesis
Casdin Capital invests in all aspects of today‚„s Life Sciences revolution by leveraging the accelerating capability to read and manipulate molecular information. The firm partners with companies in Healthcare, BioTech, Synthetic Biology, and Technology to create value through patience, persistence, and strong relationships.
Portfolio
23andMe
4D Molecular Therapeutics
908 devices
A2 Biotherapeutics
AbSci
Adaptive Biotechnologies
Affinia
Alector
Aledade
AmplifyBio